Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)
Introduction. Coronavirus infection is an acute viral disease with a predominant lesion of the upper respiratory tract caused by an RNA-containing virus of the Coronaviridae family. However, it is known that neutralizing antibodies play an important role in antiviral therapy because they effectively...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-05-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|